Related content

Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis

By Yamada Ryo   Suzuki Akari   Yamamoto Kazuhiko  

Future Rheumatology, Vol. 1, Iss. 2, 2006-04 ,pp. : 249-258

Future Medicine

Access to resources Recommend Favorite

Association of Anti-cyclic Citrullinated Peptide Antibodies with Clinical and Radiological Disease Severity in Rheumatoid Arthritis

By  

Current Rheumatology Reviews, Vol. 10, Iss. 2, 2014-09 ,pp. : 136-143

Bentham Science Publishers

Access to resources Recommend Favorite

Association of anticyclic citrullinated peptide antibodies with extra-articular manifestations, gender, and tabagism in rheumatoid arthritis patients from southern Brazil

By Goeldner Isabela  

Clinical Rheumatology, Vol. 30, Iss. 7, 2011-07 ,pp. : 975-980

Springer Publishing Company

Access to resources Recommend Favorite

The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica

By Ceccato F.   Roverano S.   Barrionuevo A.   Rillo O.   Paira S.  

Clinical Rheumatology, Vol. 25, Iss. 6, 2006-11 ,pp. : 854-857

Springer Publishing Company

Access to resources Recommend Favorite

Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis

By Grootenboer-Mignot S   Nicaise-Roland P   Delaunay C   Meyer O   Chollet-Martin S   Labarre C  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 4, 2004-07 ,pp. : 218-220

Informa Healthcare

Access to resources Recommend Favorite